Hypercholesterolemia Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Hypercholesterolemia stocks.

Hypercholesterolemia Stocks Recent News

Date Stock Title
Nov 20 MDGL Novo semaglutide data in MASH could negatively impact Madrigal's Rezdiffra
Nov 20 IONS Ionis Pharmaceuticals, Inc. (IONS): Among the Best Genomics Stocks to Buy Right Now
Nov 18 ALNY Alnylam releases encouraging interim data on nucresiran for ATTR amyloidosis
Nov 18 RGNX Regenxbio surges 10% as it launches pivotal phase of muscular dystrophy asset trial
Nov 18 IONS Here's Why Ionis Pharmaceuticals (IONS) is Poised for a Turnaround After Losing -13.46% in 4 Weeks
Nov 18 ALNY ALNY Reports Sustained 6-Month Efficacy Data From Amyloidosis Study
Nov 18 ALNY Alnylam reveals trial outcomes of nucresiran for ATTR amyloidosis treatment
Nov 18 RGNX REGENXBIO INITIATES PIVOTAL PHASE OF AFFINITY DUCHENNE® TRIAL OF RGX-202 GENE THERAPY AND REPORTS POSITIVE FUNCTIONAL DATA
Nov 18 RGNX FDA endorses speedy approval path for Regenxbio Duchenne gene therapy
Nov 18 MDGL The first MASH drug could open the door for others — including GLP-1s
Nov 17 ALNY Alnylam Announces Interim Phase 1 Data of Nucresiran (ALN-TTRsc04) Showing Rapid Knockdown of TTR that is Sustained at Six Months Following a Single Dose
Nov 15 MDGL Madrigal Pharmaceuticals gains amid takeover speculation
Nov 15 RGNX Regenxbio down 13% ahead of data readout for muscular dystrophy asset
Nov 15 ABUS Arbutus’ Imdusiran Achieves Functional Cure in cHBV Patients when Combined with a Short Course of Interferon
Nov 15 ABUS Arbutus and Barinthus Bio Announce New Data from the IM-PROVE II Trial Showing that the Addition of Nivolumab Increased Rates of HBsAg Loss in People with Chronic Hepatitis B
Nov 15 MDGL John Paulson's Strategic Moves in Q3 2024: A Focus on Anglogold Ashanti PLC
Nov 14 MDGL Paulson & Co. exits AngloGold Ashanti, boosts Madrigal Pharma among Q3 moves
Hypercholesterolemia

Hypercholesterolemia, also called high cholesterol, is the presence of high levels of cholesterol in the blood. It is a form of hyperlipidemia, high blood lipids, and hyperlipoproteinemia (elevated levels of lipoproteins in the blood).Elevated levels of non-HDL cholesterol and LDL in the blood may be a consequence of diet, obesity, inherited (genetic) diseases (such as LDL receptor mutations in familial hypercholesterolemia), or the presence of other diseases such as type 2 diabetes and an underactive thyroid.Cholesterol is one of three major classes of lipids which all animal cells use to construct their membranes and is thus manufactured by all animal cells. Plant cells do not manufacture cholesterol. It is also the precursor of the steroid hormones and bile acids. Since cholesterol is insoluble in water, it is transported in the blood plasma within protein particles (lipoproteins). Lipoproteins are classified by their density: very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), low density lipoprotein (LDL) and high density lipoprotein (HDL). All the lipoproteins carry cholesterol, but elevated levels of the lipoproteins other than HDL (termed non-HDL cholesterol), particularly LDL-cholesterol, are associated with an increased risk of atherosclerosis and coronary heart disease. In contrast, higher levels of HDL cholesterol are protective.Avoiding trans fats and replacing saturated fats in adult diets with polyunsaturated fats are recommended dietary measures to reduce total blood cholesterol and LDL in adults. In people with very high cholesterol (e.g., familial hypercholesterolemia), diet is often not sufficient to achieve the desired lowering of LDL, and lipid-lowering medications are usually required. If necessary, other treatments such as LDL apheresis or even surgery (for particularly severe subtypes of familial hypercholesterolemia) are performed. About 34 million adults in the United States have high blood cholesterol.

Browse All Tags